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Background: Modelling studies are used widely to help inform decisions about health care and policy and their
use is increasing. However, in order for modelling to gain strength as a tool for health policy, it is critical that key
model factors are transparent so that users of models can have a clear understanding of the model and its
limitations.Reporting guidelines are evidence-based tools that specify minimum criteria for authors to report their
research such that readers can both critically appraise and interpret study findings. This study was conducted to
determine whether there is an unmet need for population modelling reporting guidelines.
Methods: We conducted a review of the literature to identify: 1) guidance for reporting population modelling
studies; and, 2) evidence on the quality of reporting of population modelling studies. Guidance for reporting was
analysed using a thematic approach and the data was summarised as frequencies. Evidence on the quality of
reporting was reviewed and summarized descriptively.
Results: There were no guidelines that specifically addressed the reporting of population modelling studies. We
identified a number of reporting guidelines for economic evaluation studies, some of which had sections that were
relevant population modelling studies. Amongst seven relevant records, we identified 69 quality criteria that have
distinct reporting characteristics. We identified two papers that addressed reporting practices of modelling studies.
Overall, with the exception of describing the data used for calibration, there was little consistency in reporting.
Conclusions: While numerous guidelines exist for developing and evaluating health technology assessment and
economic evaluation models, which by extension could be applicable to population modelling studies, there is
variation in their comprehensiveness and in the consistency of reporting these methods. Population modelling
studies may be an area which would benefit from the development of a reporting guideline.Introduction
Modelling studies are used widely to help inform deci-
sions about health care and policy and their use is in-
creasing [1,2]. A model is “an analytical methodology
that accounts for events over time and across popula-
tions, that is based on data drawn from primary or
secondary sources. . .” and in the context of health care-
evaluation “. . .whose purpose is to estimate the effects
of an intervention on valued health consequences and
costs” [3]. Its value lies not only in its results, but also in
its ability to reveal the connections between its data and
assumptions and model outputs [3]. But, as pointed out
by Garrison, models don’t have to be mathematically
sophisticated to be hard to follow [4]. For these reasons,* Correspondence: cbennett@ohri.ca
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distribution, and reproduction in any mediuma model should not be a “black box” for the end-user
but be as transparent as possible [3].
To address the problem of poorly reported research,
multiple reporting guidelines have been developed and
validated for use with a number of study designs.
Reporting guidelines are evidence-based tools that em-
ploy expert consensus to specify minimum criteria for
authors to report their research such that readers can
both critically appraise and interpret study findings [5,6].
The EQUATOR Network, an international initiative
whose aim is to improve the reliability of medical re-
search by promoting transparent and accurate reporting
of research studies, indexes more than 100 reporting
guidelines on their Web site (www.equator-network.org).
The growth in the number and range of reporting
guidelines has prompted guidance on how to develop
one using a well-structured development process [6].
This study addresses the needs assessment-that is, to de-
termine whether there is a need for population modellingCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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our study were: to locate and assess any existing report-
ing guidelines for population modelling studies; to iden-
tify key quality criteria for the reporting of population
modelling studies; and to determine if and how these cri-
teria are being reported in the literature.Methods
We began this process with a search of the MEDLINE
electronic database (MEDLINE (1950 – February 2011)
via Ovid. Our electronic search strategy (see appendix),
developed in consultation with a library scientist, was
pragmatically designed to avoid being overwhelmed with
irrelevant records. We hand-searched the reference lists
and used the related articles feature in PubMED for all
papers meeting our eligibility criteria. In addition, we
reviewed relevant textbooks and Web sites. One reviewer
screened the titles and abstracts of all unique citations to
identify papers that met our inclusion criteria—that is, Eng-
lish language papers that provided explicit guidance on the
reporting of population modelling studies or provided evi-
dence on the quality of reporting of population modelling
studies in the health science literature. The full-text report
of each record passing title/abstract screening was retrieved
and reviewed by the research team and its inclusion/exclu-
sion status was established.
For records that provided explicit guidance on report-
ing of population modelling studies, the list of criteria
identified was analysed using a thematic approach andUnique records identified through 
search (n = 806)
Records screened (n = 61)
Full-text records assessed for 
eligibility (n = 30)
Records included in qualitative 
synthesis
5 – guidance for reporting modelling 
studies 
2 – quality of reporting modelling 
studies and guidance for reporting
Figure 1 Flow diagram of records – guidelines for reporting modellin
studies.the data was summarised as frequencies. For those
papers that presented evidence on the quality of report-
ing of population modelling studies, we identified the
aspects of reporting that were assessed and summarised
the results descriptively.
Results and discussion
We identified 806 unique records through our search
strategy, 30 full-text articles were reviewed to determine
eligibility (Figure 1).
Existence of guidelines for modelling studies
There were no guidelines that specifically addressed the
reporting of population modelling studies. However,
there were a number of reporting guidelines for eco-
nomic evaluation studies: one of which was related to
modelling [7] and one included a section which focused
on the generalisability of modelling studies [8]. Add-
itionally, we identified one paper that provided reporting
guidance for a specific aspect of simulation modelling
methodology – calibration [9].
Numerous guidelines have been published defining
good practice for the conduct of economic evaluations
in general and model-based evaluations in particular.
We identified two papers that provided guidance for
assessing the quality of decision-analytic modelling stud-
ies [3,10] and one paper that provided guidance for
assessing validation of population-based disease simula-
tion models [2].Records excluded (n = 31)
Full-text records excluded (n = 23)
- no guidance specific for reporting 
modelling studies 
- quality of reporting not addressed
g studies and evidence on the quality of reporting of modelling
Table 1 Checklist items for reporting modelling studies
Dimension of
Quality




Is there a clear statement of the decision problem? x x x
Is the objective of the evaluation specified and consistent with
the stated decision problem?
x x
Is the primary decision-maker specified? x x
Scope/perspective Is the perspective of the model clearly stated? x x x
Are the model inputs consistent with the stated perspective? x x
Are definitions of the variables in the model justified? x
Has the scope of the model been stated and justified? x x
Are the outcomes of the model consistent with the perspective,




Is the structure of the model consistent with a coherent theory
of the health condition under evaluation?
x x x
Are the sources of data used to develop the structure of the
model specified?
x





Are the structural assumptions clearly stated and justified? x x x x
Are the structural assumptions reasonable given the overall




Is there a clear definition of the options under evaluation? x x x
Have all feasible and practical options been evaluated? x
Is there justification for the exclusion of feasible options? x
Model type Is the chosen model type appropriate given the decision
problem and specified causal relationships within the model?
x x x
Time horizon Is the time horizon of the model sufficient to reflect all
important differences between options?
x x x
Are the time horizon of the model, the duration of treatment




Do the disease states (state transition model) or the pathways
(decision tree model) reflect the underlying biological process
of the disease in question and the impact of the interventions?
x x x
Cycle length Is the cycle length justified? x x x
Parsimony Is there indication that the structure of the model is as simple
as possible and that any simplifications are justified?
x
DATA
Data identification Are the data identification methods transparent and
appropriate given the objectives of the model?
x x x
Are results reported in a way that allows the assessment of the
appropriateness of each parameter input and each assumption
in the target settings?
x
Where choices have been made between data sources, are
these justified appropriately?
x x x
Where data from different sources are pooled, is this done in a
way that the uncertainty relating to their precision and possible
heterogeneity is adequately reflected?
x
Are the data used to populate the model relevant to the target
audiences (i.e., decision-makers) and settings?
x
Bennett and Manuel BMC Medical Research Methodology 2012, 12:168 Page 3 of 7
http://www.biomedcentral.com/1471-2288/12/168
Table 1 Checklist items for reporting modelling studies (Continued)
Has particular attention been paid to identifying data for the
important parameters in the model?
x
Has the quality of the data been assessed appropriately? x x x
Where expert opinion has been used, are the methods
described and justified?
x x x x
Data modelling Is the data modelling methodology based on justifiable
statistical and epidemiological techniques?
x x
Baseline data Is the choice of baseline data described and justified? x
Are transition probabilities calculated appropriately? x x x
Treatment effects If relative treatment effects have been derived from trial data,
have they been synthesized using appropriate techniques?
x x
Have the methods and assumptions used to extrapolate short-
term results to final outcomes been documented and justified?
Have alternative assumptions been explored through sensitivity
analysis?
x x x
Have assumptions regarding the continuing effect of treatment
once treatment is complete been documented and justified?
Have alternative assumptions been explored through sensitivity
analysis?
x
Risk factors Has evidence supporting the modeling of risk factors as having
an additive or multiplicative effect on baseline probabilities or
rates of disease incidence or mortality been presented?
x
Data incorporation Have all data incorporated into the model been described and
referenced in sufficient detail?
x x x
Has the use of mutually inconsistent data been justified (i.e., are
assumptions and choices appropriate)?
x
Is the process of data incorporation transparent? x x
If data have been incorporated as distributions, has the choice
of distribution for each parameter been described and justified?
x x
If data have been incorporated as distributions, is it clear that




Have the four principal types of uncertainty been addressed? x
If not, has the omission of particular forms of uncertainty been
justified?
x
Methodological Have methodological uncertainties been addressed by running
alternative versions of the model with different methodological
assumptions?
x
Structural Is there evidence that structural uncertainties have been
addressed via sensitivity analysis?
x x
Heterogeneity Has heterogeneity been dealt with by running the model
separately for different subgroups?
x x
Parameter Are the methods of assessment of parameter uncertainty
appropriate?
x x x x x
If data are incorporated as point estimates, are the ranges used
for sensitivity analysis stated clearly and justified?
x x
Which sensitivity analyses were carried out? x
CONSISTENCY
Internal consistency Is there evidence that the mathematical logic of the model has




Are any counterintuitive results from the model explained and
justified?
x x x
If the model has been calibrated against independent data,
have any differences been explained and justified?
x x
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Table 1 Checklist items for reporting modelling studies (Continued)
How was the model calibrated? x
Calibration - description of source data x x
Calibration - description of search algorithm x x
Calibration - description of goodness-of-fit metric x x
Calibration - description of acceptance criteria x x
Calibration - description of stopping rule x x
Have the results of the model been compared with those of
previous models and any differences in results explained?
x x x x
VALIDITY
Output plausibility Has evidence of face validity - evaluation by experts in the
subject matter area for a wide range of input conditions and
output variables, over varying time horizons – been presented?
x
Predictive validity Was the validity of the model tested? x x x x
Is there a description of how the validity of the model was
checked?
x x
How was the validity quantified? (e.g., % explained) x
COMPUTER
IMPLEMENTATION
Is the software used in the study listed and its choice justified? x x x
TRANSPARENCY Is the model available to the reader? x
Is a detailed document describing the calibration methods
available?
x
Do the authors provide relevant appendices? x
SPONSORSHIP Is disclosure of relationship between study sponsor and
performer of the study provided?
x
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Amongst the relevant records that were analysed, we
identified 69 quality criteria that have distinct reporting
characteristics (Table 1).
We identified 22 items relating to the structure of the
model and broadly classified them into 10 domains: 1)
statement of decision problem/objective; 2) statement of
scope/perspective; 3) rationale for structure; 4) structural
assumptions; 5) strategies/comparators; 6) model type;
7) time horizon; 8) disease states/pathways; 9) cycle
length; and, 10) parsimony.
We identified 28 items related to data issues and
broadly classified them into 11 domains: 1) data identifi-
cation; 2) data modelling; 3) baseline data; 4) treatment
effects; 5) risk factors; 6) data incorporation; 7) assess-
ment of uncertainty; 8) methodological; 9) structural;
10) heterogeneity; and, 11) parameter.
We identified 14 items related to consistency (internal
and external) and validity (output plausibility and pre-
dictive validity). The final five items fell under computer
implementation, transparency or funding.
The items are not mutually exclusive, and there is
overlap if one takes into account implicit and explicit
considerations. Even considering this, the records dif-
fered in terms of their comprehensiveness and the areas
of model quality they considered. No item was identifiedby all of the resources, one item appeared in five lists,
four items appeared in four lists, three items appeared in
17 lists and the remainder of the items appeared in only
one or two lists (Table 1).
Quality of reporting
We identified two papers that addressed reporting practices
of modelling studies, the first of which was a systematic re-
view of coronary heart disease policy models [11].
The authors evaluated 75 papers on the basis of
whether a sensitivity analysis was carried out, the validity
was checked, data quality was reported, illustrative
examples were provided, if the model was potentially
available to the reader (transparency), and if potential
limitations were specified or discussed. This evaluation
was based on authors reporting on the specific item in
the articles.
Relatively few papers included in the review reported
on quality issues: sensitivity analysis and assessment of
validity were reported in very few models, 33% provided
illustrative examples, working versions of the model
were available in 10%, and 19% reported on limitations
of their methodology,
The second paper examining the reporting practices of
modelling studies looked more specifically at the report-
ing of calibration methods in 154 cancer simulation
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model validation was mentioned (52%) and if a descrip-
tion of the calibration protocol was provided (66%). The
authors further characterized calibration protocols by
five components. A description of the data used as cali-
bration targets was reported by 95% of the studies and
goodness-of-fit metrics were reported in 54% of the
studies. However, the search algorithm used for selected
alternative parameter values, the criteria for identifying
parameter sets that provide an acceptable model fit, and
the stopping criteria were not well reported (quantitative
values not provided).
Few studies were identified that addressed the quality
of reporting of population modelling studies. Overall,
with the exception of describing the data used for cali-
bration, there is little consistency in the reporting of
items that have been identified as key quality items.
Conclusions
Population modelling studies can fill an important role
for policy makers. Their ability to synthesize data from
multiple sources and estimate the effects of interven-
tions can be invaluable, especially in areas where pri-
mary data collection may be infeasible. However, in
order for modelling to gain strength as a tool for health
policy, it is critical that key model factors are made
transparent so that users of models have a clear under-
standing of the model and its limitations.
While numerous guidelines exist for developing and
evaluating health technology assessment and economic
evaluation models, which by extension can be applicable
to population modelling studies, there is variation in
their comprehensiveness and in the consistency of
reporting these methods. There is evidence to suggest
that key items are under-reported.
In other areas where reporting guidelines have been
developed, there has been a favourable impact on the
transparency and accuracy of reporting [12-15]. Popula-
tion modelling studies may be another area which would
benefit from the development of a reporting guideline.
Moher and colleagues have outlined the importance of a
structured approach to the development of reporting
guidelines [6]. This paper provides results from initial
steps in this structure approach. Future work should
focus on identifying key information related to potential
sources of bias in population modelling studies and
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